7096 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
StemCell Institute KK engages in stem cell banking business. It deals with stem cell contract management, research, and development. The company was founded on August 5, 1999 and is headquartered in Tokyo, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
7096 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company